focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Wed, 08th Dec 2021 11:45

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Rockhopper Exploration PLC, up 22% at 6.38 pence, 12-month range 4.50p-12.50p. The oil & gas exploration and production company says Navitas Petroleum LP is to enter its Sea Lion oil project in the Falkland Islands. Navitas replaces Harbour Energy PLC as Rockhopper's partner in the project.

----------

Equals Group PLC, up 12% at 70.40p, 12-month range 26.10p-73.00. The fintech payments firm says it has "significantly exceeded" its full-year expectations for both adjusted earnings and revenue. Group revenue for the year to date is GBP40.4 million, up 51% from GBP26.8 million for the same period in 2020. The strong revenue performance means increased gross profit and earnings, and Equals says it has exceeded its own full-year profitability forecasts, but does not provide a figure.

----------

Clinigen Group PLC, up 10% at 901.00p, 12-month range 541.50p-912.00p. Shares hit 12-month high after the pharmaceuticals and services provider agrees to be taken private by European investment firm Triton Funds in a GBP1.2 billion deal. Under the terms, Clinigen shareholders will receive 883p a share in cash. This is a 41% premium to the ex-dividend closing share price on December 1, which was the last business day before takeover talks were first announced. Clinigen shareholders will also be entitled to receive the previously declared final dividend of 5.46p a share.

----------

AIM - LOSERS

----------

Byotrol PLC, down 16% at 4.22p, 12-month range 4.00p-7.70p. Shares in the antimicrobial technologies company hit fresh 12-month low after profit warning and says its first half performance was below expectations. For six months to September 30, swings to pretax loss of GBP141,000 from GBP1.0 million profit year before. "Whilst we expect to be both profitable and cash generative in the second half of the year, with these uncertainties it is difficult to predict the quantum at this juncture. At present we are expecting IP sales to offset the majority of the anticipated shortfall in profit on product sale, but projecting the timing of IP sales is even more uncertain, so we feel it prudent to now reduce market guidance for the current financial year," it says.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Mar 2020 09:25

UK BROKER RATINGS SUMMARY: easyJet Gets Double Upgrade To Buy From UBS

UK BROKER RATINGS SUMMARY: easyJet Gets Double Upgrade To Buy From UBS

Read more
26 Feb 2020 09:35

UK BROKER RATINGS SUMMARY: Berenberg Cuts Morrisons, Raises Sainsbury

UK BROKER RATINGS SUMMARY: Berenberg Cuts Morrisons, Raises Sainsbury

Read more
25 Feb 2020 13:15

Tuesday broker round-up

(Sharecast News) - Redrow: Jefferies upgrades to buy with a target price of 981p.

Read more
25 Feb 2020 09:25

Clinigen Hikes Dividend As Profit Almost Doubles In First Half

Clinigen Hikes Dividend As Profit Almost Doubles In First Half

Read more
18 Feb 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
16 Jan 2020 11:02

Clinigen sees FY revenues and profits improving

(Sharecast News) - Pharmaceutical company Clinigen expects full-year revenues and gross profits to have improved during its recently wrapped up trading year.

Read more
16 Jan 2020 10:06

Clinigen Reiterates Annual Forecasts As Interim Revenue Surges

Clinigen Reiterates Annual Forecasts As Interim Revenue Surges

Read more
14 Jan 2020 09:00

Clinigen Signs Agreement With Iovance For Supply Of Proleukin

Clinigen Signs Agreement With Iovance For Supply Of Proleukin

Read more
6 Jan 2020 14:34

Clinigen, Orphazyme To Make Arimoclomol Available For NPC Patients

Clinigen, Orphazyme To Make Arimoclomol Available For NPC Patients

Read more
16 Dec 2019 13:18

Monday broker round-up

(Sharecast News) - Tullow Oil: HSBC downgrades to reduce with a target price of 50p.

Read more
26 Nov 2019 16:32

Clinigen Reiterates Gross Profit Guidance Following General Meeting

Clinigen Reiterates Gross Profit Guidance Following General Meeting

Read more
22 Nov 2019 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
19 Nov 2019 16:07

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
31 Oct 2019 15:41

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
15 Oct 2019 12:47

Tuesday broker round-up

(Sharecast News) - Ocado: JP Morgan downgrades to underweight with a target price of 1,050p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.